Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit in Bangladesh
Key facts
- Who runs it
- Hiroshima University
- Where
- Bangladesh and Japan2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 272 people, planned
- Started
- 15 Feb 2026
- Planned end
- 30 May 2026
- Type of study
- Interventional
- Treatments tested
- Education with EBP
- This is a pre- and post- quasi-experimental study.
- Record updated
- 11 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Nurse
- who is a registered nurse in Bangladesh
- who agrees to participate in this study and the EBP training
- who will stay at the ICU for 6 months. Patient
- Irrespective of age and sex, participants must be at least 18 years old
- Legal guardian of a patient consent to participation in the study
Who cannot take part
- Nurse
- Who will not directly involve patient care in ICU. Patient
- No exclusion criteria
Other criteria
- Trial 1 \& 2-
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Ventilator acquired pneumonia or pressure ulcer
Where is this trial?
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Quality of care is crucial for preventing adverse events such as infection in the intensive care units (ICUs). The most common ICU-acquired infections include pneumonia such as Ventilator Associated Pneumonia (VAP), Pressure Ulcer (PU), Medical Device Related Pressure Ulcer (MDRPU), and Central Line-Associated Bloodstream Infection (CLABSI). VAP, PU, and MDRPU are significant indicators of the quality of care, while CLABSI is a critical marker of healthcare quality in ICUs, as it is largely preventable through strict adherence to infection control protocols.
Read full original descriptionShow less
VAP is a lung infection that occurs in patients receiving mechanical ventilation for more than 48 hours. A PU is defined as localized damage to the skin or underlying tissue caused solely by pressure, while MDRPUs may also result from friction or pressure from medical devices or other objects. CLABSI is a severe infection caused by improperly inserted or maintained central venous catheters, which underscores the need for stringent catheter management protocols.
The group in the trial
- Experimental: Trial 1: All Nurses in GICU; Trial 2: All patients admitted in the general GICUTreatment being tested
Nurses: All nurses who work at GICU of DMCH Patients: all patients who will admit at the assigned GICU during the study period of DMCH
Treatment: Education with EBP and This is a pre- and post- quasi-experimental study.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evidence-Based Nursing to Reduce Adverse Events Regarding Ventilator Associated Pneumonia, Pressure Injuries and Central Line Bloodstream Infection in Intensive Care Unit: A Quasi-experimental Study in Bangladesh
- Criteria questions
- Built from NCT07299799, who can take part
- Record updated
- 11 February 2026